Farringdon Capital’s Cardinal Health CAH Stock Holding History

Farringdon Capital’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,073	Closed	-$221K	–	396
2025 Q4	$221K	Sell	1,073 -223	-17%	-$42K	0.05%	378
2025 Q3	$203K	Buy	+1,296	New	+$200K	0.05%	406

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Farringdon Capital's CAH Position: Q1 2026 in Review

Farringdon Capital sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 1,073 shares — an estimated $221K sold.

Farringdon Capital first reported a position in CAH in Q3 2025 and held it in 2 quarters. The position peaked at $221K in Q4 2025. 1,433 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

Farringdon Capital reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
Farringdon Capital sold 1,073 Cardinal Health shares in Q1 2026, an estimated $221K.
Farringdon Capital first reported a position in Cardinal Health in Q3 2025 and held it in 2 quarters.
Farringdon Capital's Cardinal Health position peaked at $221K in Q4 2025.
1,433 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.